Stockscreener 앱 받기
0.00
100.00%
-0.2071
시간 외 거래:
.13
0.13
+
전일 마감가:
$0.2071
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$17.18M
수익:
$2.41M
순이익/손실:
$-42.50M
주가수익비율:
0.00
EPS:
-0.9
순현금흐름:
$-36.15M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$2.40
리넬리틱스 Stock (RNLX) Company Profile
명칭
Renalytix Plc Adr
전화
44 29 2071 0570
주소
FINSGATE, LONDON
RNLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RNLX
Renalytix Plc Adr
|
0.00 | 17.18M | 2.41M | -42.50M | -36.15M | -0.90 |
|
VEEV
Veeva Systems Inc
|
233.38 | 37.89B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.61 | 12.89B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
58.75 | 10.97B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
61.85 | 9.74B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
111.97 | 9.70B | 1.15B | 96.70M | -161.99M | 1.09 |
리넬리틱스 Stock (RNLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-01-18 | 개시 | H.C. Wainwright | Buy |
| 2022-01-04 | 개시 | BTIG Research | Buy |
| 2021-10-04 | 개시 | Guggenheim | Buy |
| 2021-07-02 | 개시 | Berenberg | Buy |
| 2020-08-11 | 개시 | Stifel | Buy |
리넬리틱스 주식(RNLX)의 최신 뉴스
Renalytix restructures option plan for top management - Investing.com
Renalytix executives engage in share transactions - Investing.com
Stock Market Recap: Renalytix Plc ADR (RNLX) Concludes at 0.21, a 5.66 Surge/Decline - The Dwinnex
Commencement of trading on OTCQB in the United States - StockTitan
What was Renalytix Plc ADR (RNLX)’s performance in the last session? - US Post News
Renalytix Plc ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
Ratios in Focus: Analyzing Renalytix Plc ADR (RNLX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Renalytix AI stock hits 52-week low at $0.22 amid market challenges - Investing.com
Renalytix Plc ADR (RNLX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
There is no way Renalytix Plc ADR (RNLX) can keep these numbers up - SETE News
How analysts predict Renalytix Plc ADR (RNLX) will perform this quarter? - US Post News
Renalytix Plc ADR (RNLX) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Investor’s Delight: Renalytix Plc ADR (RNLX) Closes Strong at 0.31, Up 7.31 - The Dwinnex
Renalytix Plc ADR (RNLX) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Analyzing RNLX’s price-to-book ratio for the last quarter - US Post News
Renalytix Plc ADR (RNLX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Closing Figures: Renalytix Plc ADR (RNLX)’s Negative Finish at 0.31, Down -23.14 - The Dwinnex
Form 8.5 (EPT/RI)-Renalytix Plc - GlobeNewswire Inc.
Investing in Renalytix Plc ADR (RNLX) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Examining Renalytix Plc ADR (RNLX) more closely is necessary - US Post News
Renalytix AI shares hold buy rating from HC Wainwright - Investing.com
Renalytix Partners with Steno for Kidney Care in Europe - Investing.com
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination - Yahoo Finance UK
Renalytix faces delisting from Nasdaq over noncompliance - Investing.com
Medicare sets $950 price for Renalytix kidney test - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Investing.com South Africa
Fragrant Prosperity slumps as reverse takeover falls through - Proactive Investors USA
리넬리틱스 (RNLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.99%
0.86%
자본화:
|
볼륨(24시간):